US Government, Pfizer ‘All Agreed’ to Delay Decision on Company’s COVID-19 Vaccine for Young Children: Bourla

A child wears a pin she received after receiving her first dose of the Pfizer COVID-19 vaccine in Southfield, Mich., on Nov. 5, 2021. Jeff Kowalsky/AFP via Getty Images

The U.S. government and Pfizer reached an agreement to delay the U.S. regulatory decision on the company’s COVID-19 vaccine for children as young as 6 months old, Pfizer’s CEO said on March 13.

“We all agreed it’s better if we wait for the three doses to come out,” CEO Albert Bourla said on CBS' “Face the Nation.”